Fragility fracture is a serious and costly public health issue. With the growth of the elderly segment of the United States (and global) population, there is increasing incidence of metabolic bone diseases. In the U.S. alone, approximately 1.5 million fractures occur annually while the incidence of osteoporosis (low bone mass) is estimated at 14 million patients and the incidence of osteopenia (reduced bone mass) at 30 million, with a concomitant annual projected economic impact of $20 billion (
1,
2). One-third of patients admitted to U.S. hospitals for hip (femoral neck) fracture die within one year, primarily due to the rapid decline in mobility and general quality of life (
3). Improved methods for screening, diagnosis and treatment monitoring of metabolic bone disease are of great importance.
Bone strength is a key predictor of fracture risk (
4). Direct mechanical testing of bone strength is destructive and invasive. In clinical
in vivo applications, bone strength cannot be measured directly. Instead, it is estimated by the use of biomarkers. The widely accepted clinical biomarker standard for bone strength is bone mineral density (BMD), estimated by Dual-Energy X-ray Absorptiometry (DXA). In fact, the World Health Organization defines osteoporosis in terms of the DXA BMD score (
5) which is used in fracture risk assessment tools such as FRAX (
6). DXA-derived scores are predictive risk factors for fractures (
7). DXA measurements provide two-dimensional measures of bone density (the signal is integrated along the third dimension, depth) and, for that reason, cannot distinguish trabecular architecture which is important to the overall biomechanical function of bone (
8,
9) and in bone disease (e.g. osteoporosis) (
10). Currently, much is still not understood about bone strength and, therefore, noninvasive methods for characterizing bone mechanical strength are needed (
4,
11). Both trabecular and cortical bones contribute significantly to the overall ability of bones to withstand loading (
12,
13). Trabecular bone has a higher surface-to-volume ratio than cortical bone, which translates in higher metabolic activity and more rapid turnover (
14,
15). The classic technique to assess trabecular microarchitecture in patients is histomorphometry of biopsy specimens by light microscopy, most typically of the trabecular bone of the iliac crest (
16), while μCT is rapidly becoming the current standard. However, biopsy is generally a method of last resort for both patients and physicians because it is a minor surgical procedure. Furthermore, biopsy may not be statistically representative of the skeleton as a whole, and cannot be performed in load-bearing bones (which are the bones of most concern in fracture risk).
The porous geometry of trabecular bone makes it amenable to study by proton magnetic resonance methods such as spectroscopy (NMR, MRS) and imaging (MRI). Diffusible water, which is present in the interstitial (pore) space of trabecular bone, can be studied using magnetic resonance methods to probe the pore space of trabecular structure. As a result, there is strong interest in applying non-invasive, clinically applicable magnetic resonance methods for the
in vivo study of trabecular bone structure (
17,
18).
Other noninvasive imaging modalities, based on high-resolution MRI (
18–
25), X-ray Computed Tomography (CT) and Ultrasound (US) (
26,
27) seek to improve fracture risk assessment by characterizing the microarchitecture of trabecular bone and estimating bone mechanical properties by post-processing of digitized images (
28–
30). Considerable effort has been expended in the development of high-resolution micro-MRI to spatially resolve trabeculae (
18,
31–
35), as well as in the development of software to derive accurate imaging-based metrics that potentially correlate with biomechanical properties of healthy, aging, or diseased bone. These methods could yield statistical parameters to describe the microarchitecture, building on classic histomorphometry results (
19,
21,
25,
28,
36–
45). Furthermore, solid state MRI is being developed to measure solid bone composition, another factor in bone strength and metabolic state (
46). Additionally, much work has been done on the measurement of relaxation times, more specifically the reversible component

of the transverse relaxation time

(
47–
49). Relaxation times may be influenced by static microscopic magnetic susceptibility distributions (resulting from the bone structure and geometry), but also by a number of other factors such as molecular diffusion through the resulting magnetic field gradients chemical exchange, and the presence of paramagnetic ions. Therefore, relaxation times may in some cases indirectly reflect biomechanical properties such as Young’s modulus (
50); however, voxel-wise values of

(or

) are dependent on the voxel size and they reflect the average orientation of trabecular elements relative to
B0 (
51). Lastly, other MR methods of trabecular bone characterization include manipulation of multiple quantum coherences to modulate the dipolar field, but the interpretation of these results is difficult (
52–
54).
Here we focus on an alternative method, DDIF (Decay due to Diffusion in the Internal Field). The DDIF contrast is generated from differences in magnetic susceptibility in the tissue. Susceptibility imaging in itself is an active area of research (
18,
48,
50,
52,
55), but the DDIF contrast is not the same as susceptibility imaging. DDIF was originally used in studies of porous media. It was developed as a spectroscopic tool for characterizing porous media such as the rock of a petroleum reservoir, by harnessing the spin dephasing which occurs when molecules diffuse through magnetic field gradients arising from spatial variations in magnetic susceptibility among the various structural phases of the material (
56–
58). In porous media the susceptibility differences at the tissue-matrix interface result in internal field gradients that influence the proton signal due to diffusion in the porous space (
59). The DDIF method is based on a stimulated echo sequence (
56). A particle (for example a proton) diffusing in a porous medium from location
x1 to
x2, in the absence of external gradients accumulates a phase factor increment Δ
![[var phi]](/corehtml/pmc/pmcents/x03C6.gif)
given from the relation
where the symbol

denotes the local internal magnetic field at location
x and and time
t, and
γ is the gyromagnetic ratio of the proton. The echo signal is proportional to the integral of that phase factor over a measure which is the diffusion propagator in pore space. One may gain a qualitative understanding of the DDIF signal in terms of diffusion propagator eigenfunctions (
57,
60). In order to gain an intuitive understanding, it helps to visualize the case of a simple two-component material, composed of a water-like fluid and of a solid matrix. The internal field induced within the fluid in the pore space has a complex non-uniform spatial structure. Its gradient is often largest near the tissue interface, i.e. near the solid matrix surface. As a proton diffuses, performing a random walk through the pore space, it accumulates phase in proportion to the local instantaneous internal field (
Equation 1). The total phase accumulated depends on the surface-to-volume ratio of the porous material which, in turn, influences
Bi. The MR signal is an integral of the phase factor over time, resulting in signal loss (DDIF weighting) as a function of diffusion time. When the diffusion or mixing time
t is sufficiently long, each proton effectively samples all paths and the magnetization decays with a
T1-like (slower) decay. In the context of a biomedical application (bone imaging) the DDIF contrast is the result of susceptibility-induced diffusion decay from the porous structure of the trabecular bone. The DDIF contrast does not require high-resolution MRI in order to resolve the trabeculae, and it provides a diffusion contrast that is related to the geometrical structure of the trabecular bone.
The DDIF method has been previously applied
ex vivo to bovine trabecular specimens whose marrow had been removed and were immersed in saline (
61,
62). These
ex vivo studies demonstrated that DDIF correlated with the mechanical compressive strength of
ex vivo bovine bone specimens, that the measured DDIF decay constants correlated with simulated DDIF decay constants based on the trabecular bone surface geometry, and that DDIF measurements agreed well with the susceptibility differences induced by trabecular pores (approximately up to 200 μm). These
ex vivo specimens approximate well the two-component idealization, but real bone is not a simple two-component material. Bone marrow is a complex material which to first approximation can be viewed as a two-component liquid itself, comprised of slowly diffusing large lipid molecules (adipocytic, yellow, marrow) and fast diffusing watery haematopoietic red marrow containing iron-carrying hemoglobin. These components differ from each other both in diffusion and in relaxation time constants (
63–
66). In both the watery and lipid components, water is by far the most diffusible molecule, and is the dominant source of DDIF contrast. However, the reduction of water diffusion constant and of
T1 in marrow compared to bulk water may reduce the DDIF contrast and make it harder to measure experimentally. The goal of this study is to examine whether DDIF is feasible in realistic bone specimens.
This study had two major aims. First, we implemented and demonstrated a DDIF imaging sequence with reduced sensitivity to imaging gradients. Second, we examined the performance of DDIF on fresh bone specimens containing marrow and studied at physiological (body) temperature. While this is an ex vivo study, we aimed to realistically approximate the conditions of an in vivo DDIF human study in a clinical context.